Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Genomic testing can help customize treatment to target tumors.
Damon Runyon researchers are making an impact through understanding the biology and developing novel treatments.
Tumors with large numbers of genetic mutations may be especially susceptible to treatment with immunotherapy.
BO-112 helped make tumor cells more vulnerable to immunotherapy, offering a possible treatment route for hard-to-treat cancers.
Results revealed vast cellular diversity in both lung tumors and the tissue surrounding the tumor.
Jamil Rivers, 42, is the board president of METAvivor, a nonprofit breast cancer organization. She is living with metastatic breast cancer.
Researchers want to determine whether oligometastatic tumors can either prolong or improve the quality of life for patients.
I do not fear death. But like most of us, I fear great suffering.
Elevated levels of a protein called RUNX2 in human lung tumors predict a worse prognosis.
A horned dino is believed to have had osteosarcoma almost 77 million years ago.
I think about my birthday differently ever since my diagnosis of stage IIA invasive lobular breast cancer.
Three days after Thanksgiving, Alex Bartlett ended up in the emergency room with excruciating and debilitating back pain.
Based on animal studies, researchers suggest that beta blockers may help.
One finding of the project was that, on average, the genome of cancer cells contains four or five “driver” mutations.
Last year, the FDA approved three new antibody-drug conjugates for treating cancer.
A new study developed a model categorizing the disease, and a treatment’s likelihood of success, based on the tumor’s site of origin.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.